After Pfizer and BioNTech‘s COVID-19 vaccine candidate tested at a 90% efficacy rate in clinical trials, the scramble to lay out the framework for a post-coronavirus music industry is on.
Ticketmaster are among the first in the industry to begin implementing a tangible plan for concertgoers’ safety at live events moving forward. For a 2021 return to the live events industry, the ticketing company plan to use smartphone technology as a means to check consumer vaccination status before admittance.
THE PROCESS
The Ticketmaster plan will require three components in order to be put into action: the Ticketmaster mobile ticketing app, third party health companies like IBM Digital Health Pass, and a vaccine distributor.
If the plan is approved, the process for attending a Ticketmaster event would begin with a ticket purchase, and a vaccination. Once results from the vaccination and test are returned, the consumer would submit those results to a third party health service to be logged. Alternatively, if the customer has tested negative for COVID-19 within approximately 24 to 72 hours before the event was set to take place and not been vaccinated, the user would submit the negative test results to the health service.
From there, the health service would verify those results with Ticketmaster, and when approved, Ticketmaster would provide the necessary credentials for entry to the consumer. If those requirements were not met, or the consumer tested positive for the virus, admission would not be granted.
Recently, Swallow Events unveiled a similar plan that would implement pop-up testing onsite at gatherings in the United Kingdom. While Ticketmaster still has many minor details to sort out, and the Pfizer/BioNTech vaccine has yet to be approved for public usage, the ticketing giant’s plan could be one of the first steps in a return to a semblance of normalcy for the live music and events industry.
Image credit: Josh Sorenson
